Loading…

Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract

Cyclamen europaeum tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influen...

Full description

Saved in:
Bibliographic Details
Published in:Archives of virology 2019-01, Vol.164 (1), p.243-247
Main Authors: Evseenko, Vasily A., Kolosova, Natalia P., Gudymo, Anderi S., Maltsev, Semion V., Bulanovich, Julia A., Goncharova, Nataliya I., Danilchenko, Natalia V., Marchenko, Vasiliy Y., Susloparov, Ivan M., Ryzhikov, Alexander B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3
cites cdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3
container_end_page 247
container_issue 1
container_start_page 243
container_title Archives of virology
container_volume 164
creator Evseenko, Vasily A.
Kolosova, Natalia P.
Gudymo, Anderi S.
Maltsev, Semion V.
Bulanovich, Julia A.
Goncharova, Nataliya I.
Danilchenko, Natalia V.
Marchenko, Vasiliy Y.
Susloparov, Ivan M.
Ryzhikov, Alexander B.
description Cyclamen europaeum tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.
doi_str_mv 10.1007/s00705-018-4023-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2109327436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2109327436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</originalsourceid><addsrcrecordid>eNp1kU2LFDEQhoMo7rj6A7xIwIuX1krSH-mjDKsuLHjRc6hOV48ZutNjPkZnf70ZZlUQvCSk8tRbBQ9jLwW8FQDdu1gOaCoQuqpBqko9YhtRK1nprteP2QYU1JVuQV-xZzHuAUpBNU_ZlQIpm0bKDTve-hTQY8SZu2XJ3t1jcqvn68R32XlCfnA7_sOlbzwFd8SZfOLOT3Mmf48cfXI78hzHfT6WB418OPHtyc64lDLlsB6Q8sJTHihETj_LOJuesycTzpFePNzX7OuHmy_bT9Xd54-32_d3lVWdTJXUCEOnhFBDYxXauhlHNXZj3WvRThKatkEkAVb1U4ugWuwGIW03ku4Ha626Zm8uuYewfs8Uk1lctDTP6GnN0UgBvZJdrdqCvv4H3a85-LLdmdIgtW6bQokLZcMaY6DJHIJbMJyMAHOWYi5STJFizlKMKj2vHpLzsND4p-O3hQLICxDLl99R-Dv6_6m_AAkYmRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2108028865</pqid></control><display><type>article</type><title>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</title><source>Springer Nature</source><creator>Evseenko, Vasily A. ; Kolosova, Natalia P. ; Gudymo, Anderi S. ; Maltsev, Semion V. ; Bulanovich, Julia A. ; Goncharova, Nataliya I. ; Danilchenko, Natalia V. ; Marchenko, Vasiliy Y. ; Susloparov, Ivan M. ; Ryzhikov, Alexander B.</creator><creatorcontrib>Evseenko, Vasily A. ; Kolosova, Natalia P. ; Gudymo, Anderi S. ; Maltsev, Semion V. ; Bulanovich, Julia A. ; Goncharova, Nataliya I. ; Danilchenko, Natalia V. ; Marchenko, Vasiliy Y. ; Susloparov, Ivan M. ; Ryzhikov, Alexander B.</creatorcontrib><description>Cyclamen europaeum tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.</description><identifier>ISSN: 0304-8608</identifier><identifier>EISSN: 1432-8798</identifier><identifier>DOI: 10.1007/s00705-018-4023-3</identifier><identifier>PMID: 30225522</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Adjuvants, Immunologic ; Administration, Intranasal ; Animals ; Antigens ; Biomedical and Life Sciences ; Biomedicine ; Brief Report ; Cyclamen ; Cyclamen - chemistry ; Guinea Pigs ; Hemagglutinins ; Immunization ; Infectious Diseases ; Influenza ; Influenza B ; Influenza Vaccines - immunology ; Medical Microbiology ; Mucosa ; Orthomyxoviridae Infections - prevention &amp; control ; Plant Extracts - chemistry ; Plant Extracts - pharmacology ; Rhinosinusitis ; Tubers ; Vaccines ; Virology</subject><ispartof>Archives of virology, 2019-01, Vol.164 (1), p.243-247</ispartof><rights>Springer-Verlag GmbH Austria, part of Springer Nature 2018</rights><rights>Archives of Virology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</citedby><cites>FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30225522$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Evseenko, Vasily A.</creatorcontrib><creatorcontrib>Kolosova, Natalia P.</creatorcontrib><creatorcontrib>Gudymo, Anderi S.</creatorcontrib><creatorcontrib>Maltsev, Semion V.</creatorcontrib><creatorcontrib>Bulanovich, Julia A.</creatorcontrib><creatorcontrib>Goncharova, Nataliya I.</creatorcontrib><creatorcontrib>Danilchenko, Natalia V.</creatorcontrib><creatorcontrib>Marchenko, Vasiliy Y.</creatorcontrib><creatorcontrib>Susloparov, Ivan M.</creatorcontrib><creatorcontrib>Ryzhikov, Alexander B.</creatorcontrib><title>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</title><title>Archives of virology</title><addtitle>Arch Virol</addtitle><addtitle>Arch Virol</addtitle><description>Cyclamen europaeum tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.</description><subject>Adjuvants, Immunologic</subject><subject>Administration, Intranasal</subject><subject>Animals</subject><subject>Antigens</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brief Report</subject><subject>Cyclamen</subject><subject>Cyclamen - chemistry</subject><subject>Guinea Pigs</subject><subject>Hemagglutinins</subject><subject>Immunization</subject><subject>Infectious Diseases</subject><subject>Influenza</subject><subject>Influenza B</subject><subject>Influenza Vaccines - immunology</subject><subject>Medical Microbiology</subject><subject>Mucosa</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>Plant Extracts - chemistry</subject><subject>Plant Extracts - pharmacology</subject><subject>Rhinosinusitis</subject><subject>Tubers</subject><subject>Vaccines</subject><subject>Virology</subject><issn>0304-8608</issn><issn>1432-8798</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kU2LFDEQhoMo7rj6A7xIwIuX1krSH-mjDKsuLHjRc6hOV48ZutNjPkZnf70ZZlUQvCSk8tRbBQ9jLwW8FQDdu1gOaCoQuqpBqko9YhtRK1nprteP2QYU1JVuQV-xZzHuAUpBNU_ZlQIpm0bKDTve-hTQY8SZu2XJ3t1jcqvn68R32XlCfnA7_sOlbzwFd8SZfOLOT3Mmf48cfXI78hzHfT6WB418OPHtyc64lDLlsB6Q8sJTHihETj_LOJuesycTzpFePNzX7OuHmy_bT9Xd54-32_d3lVWdTJXUCEOnhFBDYxXauhlHNXZj3WvRThKatkEkAVb1U4ugWuwGIW03ku4Ha626Zm8uuYewfs8Uk1lctDTP6GnN0UgBvZJdrdqCvv4H3a85-LLdmdIgtW6bQokLZcMaY6DJHIJbMJyMAHOWYi5STJFizlKMKj2vHpLzsND4p-O3hQLICxDLl99R-Dv6_6m_AAkYmRs</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Evseenko, Vasily A.</creator><creator>Kolosova, Natalia P.</creator><creator>Gudymo, Anderi S.</creator><creator>Maltsev, Semion V.</creator><creator>Bulanovich, Julia A.</creator><creator>Goncharova, Nataliya I.</creator><creator>Danilchenko, Natalia V.</creator><creator>Marchenko, Vasiliy Y.</creator><creator>Susloparov, Ivan M.</creator><creator>Ryzhikov, Alexander B.</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20190101</creationdate><title>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</title><author>Evseenko, Vasily A. ; Kolosova, Natalia P. ; Gudymo, Anderi S. ; Maltsev, Semion V. ; Bulanovich, Julia A. ; Goncharova, Nataliya I. ; Danilchenko, Natalia V. ; Marchenko, Vasiliy Y. ; Susloparov, Ivan M. ; Ryzhikov, Alexander B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adjuvants, Immunologic</topic><topic>Administration, Intranasal</topic><topic>Animals</topic><topic>Antigens</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brief Report</topic><topic>Cyclamen</topic><topic>Cyclamen - chemistry</topic><topic>Guinea Pigs</topic><topic>Hemagglutinins</topic><topic>Immunization</topic><topic>Infectious Diseases</topic><topic>Influenza</topic><topic>Influenza B</topic><topic>Influenza Vaccines - immunology</topic><topic>Medical Microbiology</topic><topic>Mucosa</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>Plant Extracts - chemistry</topic><topic>Plant Extracts - pharmacology</topic><topic>Rhinosinusitis</topic><topic>Tubers</topic><topic>Vaccines</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evseenko, Vasily A.</creatorcontrib><creatorcontrib>Kolosova, Natalia P.</creatorcontrib><creatorcontrib>Gudymo, Anderi S.</creatorcontrib><creatorcontrib>Maltsev, Semion V.</creatorcontrib><creatorcontrib>Bulanovich, Julia A.</creatorcontrib><creatorcontrib>Goncharova, Nataliya I.</creatorcontrib><creatorcontrib>Danilchenko, Natalia V.</creatorcontrib><creatorcontrib>Marchenko, Vasiliy Y.</creatorcontrib><creatorcontrib>Susloparov, Ivan M.</creatorcontrib><creatorcontrib>Ryzhikov, Alexander B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evseenko, Vasily A.</au><au>Kolosova, Natalia P.</au><au>Gudymo, Anderi S.</au><au>Maltsev, Semion V.</au><au>Bulanovich, Julia A.</au><au>Goncharova, Nataliya I.</au><au>Danilchenko, Natalia V.</au><au>Marchenko, Vasiliy Y.</au><au>Susloparov, Ivan M.</au><au>Ryzhikov, Alexander B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract</atitle><jtitle>Archives of virology</jtitle><stitle>Arch Virol</stitle><addtitle>Arch Virol</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>164</volume><issue>1</issue><spage>243</spage><epage>247</epage><pages>243-247</pages><issn>0304-8608</issn><eissn>1432-8798</eissn><abstract>Cyclamen europaeum tubers extract (CTE) with concentration commonly used for human rhinosinusitis treatment was tested as mucosal adjuvant in experimental intranasal immunization of guinea pigs with concentrated commercially available influenza trivalent vaccine and subsequent infection with influenza strain A/California/04/2009 H1N1pdm. Dual intranasal immunization with vaccine compound consisting of 7.5 µg of each hemagglutinin and 500 µg of CTE in 50 µl induced reciprocal GMT on day 21 after immunization 40 (5-640) against H1N1pdm; 43.20 (5-1280) against H3N2; 10.80 (5-80) against influenza B. Animals with HI titers 1/80 against cell-derived antigen were completely protected against challenge with A/California/04/2009 H1N1pdm09.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>30225522</pmid><doi>10.1007/s00705-018-4023-3</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-8608
ispartof Archives of virology, 2019-01, Vol.164 (1), p.243-247
issn 0304-8608
1432-8798
language eng
recordid cdi_proquest_miscellaneous_2109327436
source Springer Nature
subjects Adjuvants, Immunologic
Administration, Intranasal
Animals
Antigens
Biomedical and Life Sciences
Biomedicine
Brief Report
Cyclamen
Cyclamen - chemistry
Guinea Pigs
Hemagglutinins
Immunization
Infectious Diseases
Influenza
Influenza B
Influenza Vaccines - immunology
Medical Microbiology
Mucosa
Orthomyxoviridae Infections - prevention & control
Plant Extracts - chemistry
Plant Extracts - pharmacology
Rhinosinusitis
Tubers
Vaccines
Virology
title Intranasal immunization of guinea pig with trivalent influenza antigen adjuvanted by Cyclamen europaeum tubers extract
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intranasal%20immunization%20of%20guinea%20pig%20with%20trivalent%20influenza%20antigen%20adjuvanted%20by%20Cyclamen%20europaeum%20tubers%20extract&rft.jtitle=Archives%20of%20virology&rft.au=Evseenko,%20Vasily%20A.&rft.date=2019-01-01&rft.volume=164&rft.issue=1&rft.spage=243&rft.epage=247&rft.pages=243-247&rft.issn=0304-8608&rft.eissn=1432-8798&rft_id=info:doi/10.1007/s00705-018-4023-3&rft_dat=%3Cproquest_cross%3E2109327436%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-28a0b73113b5c3ac45dd3d7d49816f20565aae10c39f6a036a7b12c7de89bccc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2108028865&rft_id=info:pmid/30225522&rfr_iscdi=true